-
Chemesis International Inc. Announces Second Tranche of Convertible Debenture Offering
[ad_1] Chemesis International Inc. (CSE:CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is happy to announce that it intends to…
Read More » -
Biotech
-390x220.jpg)
Sensorion’s vertigo drug hits tolerability endpoint in phase 2
[ad_1] A phase 2a trial of Sensorion’s vertigo seliforant has met its major tolerability endpoint. The trial discovered the histamine…
Read More » -
Biotech
-390x220.jpg)
Axovant buys more gene therapies, setting it up for a busy 2019
[ad_1] Axovant has licensed two gene therapies from the University of Massachusetts Medical School (UMMS). The deal accelerates Axovant’s evolution…
Read More » -
Extendicare Announces December 2018 Dividend of C$0.04 per Share Toronto Stock Exchange:EXE
[ad_1] MARKHAM, Ontario, Dec. 13, 2018 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) introduced that it…
Read More » -
Cannabis
Kaya Holdings Postpones Annual Shareholder Conference Call
[ad_1] © 2018 D.M.O. Holdings Corp. – DMOholdings.com DISCLAIMER: DMO Holdings Corp., which owns MJobserver.com, just isn’t registered with any…
Read More » -
Cannabis
Biome Receives DTC Eligibility | Investing News Network
[ad_1] Biome Grow Inc. (“Biome”or the “Company”) (CSE:BIO) (OTC:ORTFF) (FSE:60TA) publicizes that it has secured The Depository Trust Company (“DTC”) eligibility for its shares traded…
Read More » -
Biotech
CRISPR controls obesity in mice by amplifying rather than editing genes
[ad_1] The genes SIM1 and MC4R regulate food consumption by signaling the sensation of being full, which is why mutations…
Read More » -
News
Get the best Tax Refund (and file for FREE)
[ad_1] Congratulations! ALSO READ: Socially Responsible Investing: Does is really work? You have efficiently made it to maturity. You at…
Read More » -
Biotech
Sunovion, PsychoGenics nondopamine schizophrenia drug meets phase 2 endpoint
[ad_1] Sunovion Pharmaceuticals and PsychoGenics unveiled constructive phase 2 outcomes for a brand new schizophrenia therapy that doesn’t bind to…
Read More » -
Nobel Prize-Winning Chemists: Misguided GMO Fears Could Hinder Technology’s Societal Benefits
[ad_1] On Friday, December 7, two winners of the 2018 Nobel prize for Chemistry – American chemical engineer Frances Arnold…
Read More »
